Navigation Links
The Rev. Michael J. O'Connell Assumes Chairmanship of Hazelden Foundation Board of Trustees
Date:6/4/2009

CENTER CITY, Minn., June 4 /PRNewswire-USNewswire/ -- The Hazelden Foundation, one of the world's largest and most respected private, not-for-profit alcohol and drug addiction treatment centers, announced today that the Rev. Michael J. O'Connell has been named the new chair of its Board of Trustees. O'Connell succeeds Norbert J. Conzemius, who served as chair for two years.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/CGTU038LOGO)

"The Rev. O'Connell has been a dedicated member of the Hazelden Board of Trustees since 2004, and we are delighted to work with him in his new capacity as board chair," said Mark Mishek, Hazelden's president and CEO. "We also thank Norbert for his valuable service and continuing commitment to Hazelden and its mission to help people sustain lifelong recovery from addiction to drugs and alcohol."

O'Connell currently serves as pastor at Church of the Ascension in North Minneapolis and is the former rector at Minneapolis' Basilica of Saint Mary, a parish noted for its pastoral care and work with the poor. O'Connell has spearheaded a number of local initiatives such as the Jeremiah Program, which helps single mothers attain self-sufficiency; worked closely with local Jewish, Christian and Islamic congregations to promote interfaith dialogue and understanding; led trips with Catholic and Jewish congregants to holy sites around the world; and commissioned a sacred Holocaust memorial oratorio, "To Be Certain of the Dawn," as a gift to the Jewish people in 2001.

O'Connell also serves as a board member for the Saint John's Graduate School of Theology, Greater Twin Cities United Way, Friends of Ascension School Board, Lundstrum Center for the Performing Arts, Friends of Catholic Urban Schools, and the Robins, Kaplan, Miller & Ciresi Foundation for Children. He holds a master's degree from the University of St. Thomas.

"It's an honor for me to serve in this important role since my lifelong work has always been about helping people," said Rev. O'Connell. "And I will continue to do so in supporting Hazelden's promise of offering the best opportunity for lifelong recovery for those seeking help for addiction."

About Hazelden

Hazelden, a national nonprofit organization founded in 1949, helps people reclaim their lives from the disease of addiction. With nearly 60 years of knowledge and experience, Hazelden offers a comprehensive approach to addiction that addresses the full range of patient, family, and professional needs, including treatment and continuing care for youth and adults, research, higher learning, public education and advocacy, and publishing. It has facilities in Minnesota, Oregon, Illinois, and New York. For more information, visit www.hazelden.org.


'/>"/>
SOURCE Hazelden Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
2. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
3. Clarient Names Michael J. Pellini, M.D. Chief Operating Officer
4. Digital Healthcare Announces Dr. Michael Fleming Joins Executive Team as Medical Director
5. Michael J. Fox Foundation Commits Up to $2 Million for PD Drug Development Under Target Validation 2008
6. BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales
7. BioSeek Appoints Michael C. Venuti, Ph.D., Chief Executive Officer
8. Irene Hegeman Richard, MD, Appointed Senior Medical Advisor to The Michael J. Fox Foundation
9. Actress Jenifer Lewis, Authors Dr. Michael Eric Dyson and Susan Taylor Among Featured Speakers for Senator Hughes Behavioral Mental Health Summit
10. Michael J. Fox Foundation Launches Rapid Response Innovation Awards 2008 Following Strong Inaugural Year Response
11. Siemens Medical Solutions Michael Long Recognized as one of Computerworlds 2008 Premier 100 IT Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... From March 4 through 6, ... Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C. , ... condition of hyperhidrosis (excessive sweating) and its treatment options. Specifically, the company will ...
(Date:2/11/2016)... ... February 11, 2016 , ... Husted Kicking has completed its ... on February 6th & 7th, 2016 according to kicking coach Michael Husted. , “This ... to the NFL’s combine in Indianapolis,” says Husted. “The NFL uses a third party ...
(Date:2/11/2016)... , ... February 11, 2016 , ... The book, “Computers ... IT services, what questions to ask your IT consultant before signing a contract and ... your computer network. , “With companies relying heavily on e-mail and technology, it’s more ...
(Date:2/11/2016)... AZ (PRWEB) , ... February 11, 2016 , ... As ... with support of the Million Dollar Round Table Foundation (MDRTF), has gifted $10,000 to ... according to Colleen’s Dream Foundation President Billy Cundiff. , “We are honored to support ...
(Date:2/10/2016)... ... February 10, 2016 , ... The 9th annual meeting ... Congress (WMIC), will be held in New York City, NY on September 7 ... The congress will highlight and emphasize how imaging reveals a greater understanding of ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... The primary goal of this research is ... the usage of liquid biopsy. Key information the survey ... Timeframe of liquid biopsy adoption amidst future users - ... type - Sample inflow to conduct liquid biopsy tests ... and so on. - Correlation analysis of sample type ...
(Date:2/11/2016)... Calif., Feb. 11, 2016 PRO-DEX, INC. (NasdaqCM: PDEX) ... ended December 31, 2015. The Company also filed its Quarterly ... year 2016 with the Securities and Exchange Commission today. ... 31, 2015 --> --> ... increased $2.6 million, or 95%, to $5.4 million from $2.8 ...
(Date:2/11/2016)...  Kindred Biosciences, Inc. (NASDAQ: KIN ), a ... of pets, today announced the submission to FDA of ... Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline ... for the control of pyrexia (fever) in horses were ... --> The Chemistry, Manufacturing, and Controls ...
Breaking Medicine Technology: